Upcoming Events
  1. ALTG open MAC and SAC meetings

    November 20
  2. Virtual 2020 World Conference on Lung Cancer Singapore

    January 28, 2021 @ 8:00 am - January 31, 2021 @ 5:00 pm

Thoracic oncology highlights from ASCO2020 webinar- recording and evaluation survey

Please fill in the evaluation survey if you have not already done so by clicking on the survey icon at the base of your webinar console.

Please access the recording and evaluation survey here

ALTG awarded $12 million in funding

The ALTG is pleased to announce over $12 million in funding has been successfully awarded to ALTG, NHMRC Clinical Trial Centre and the Australian Genomic Cancer Medicine Centre for the ASPiRATION project. In this ground-breaking precision medicine study, led by ALTG President A/Prof Nick Pavlakis and ALTG Scientific Advisory Committee Chair, Prof Ben Solomon, ASPiRATION will explore the benefit of routine comprehensive genomic profiling in 1000 newly-diagnosed metastatic, non-squamous, NSCLC patients in Australia. The enhanced genomic profiling will assist in personalising patient care by matching patients to targeted treatments as early as possible to improve patient outcomes.

Preceptorship in Lung Cancer

At the ALTG’s inaugural Preceptorship in Lung Cancer, 49 advanced trainees and junior consultants were given the opportunity to review, present and discuss the latest developments in lung cancer treatment over a two day intensive learning course.

In April 2015 the ALTG hosted the inaugural Preceptorship in Lung Cancer in Sydney, convened by Eva Segelov and facilitated by Nick Pavlakis, Shane White, Prunella Blinman, Chris Karapetis, Stephen Clarke and Michael Millward. This two day intensive learning course for advanced trainees and junior consultants in Medical, Radiation and Surgical Oncology offered participants the chance to actively learn in small groups, utilising the Harvard short course model across a range of key topics in thoracic cancer:

  • Basic biology and translational science of lung cancer and current therapies
  • Seminal papers in adjuvant therapy of lung cancer
  • Seminal papers in therapy of metastatic lung cancer
  • Treatment paradigms for metastatic lung cancer
  • Treatment pathways involving lung resection to achieve cure

Feedback from participants was overwhelmingly positive and we are currently planning the 2016 programme.

Contact Ros if you would like to receive a copy of the post-event report.